Skip to main content

Capula Management Ltd

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1557017 Grand Cayman, E9

Position in VRTX

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$110,295
+$110,295 QoQ
Shares Held
247
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Derivatives in VRTX

reported options exposure · as of Mar 31, 2026
CallValue
$357,232
CallShares
800
PutValue
$848,426
PutShares
1,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Capula Management Ltd holds $59,978,370 across 6 Biotechnology names. VRTX ranks #6 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 VRTX
Vertex Pharmaceuticals Inc / Ma
This page
247 $110,295

All Filings in VRTX

Export CSV
31 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $110,295 247
2026-03-31 $357,232 800
2026-03-31 $848,426 1,900
2025-12-31 $181,344 400
2025-12-31 $181,344 400
2025-09-30 $301,562 770
2025-09-30 $587,460 1,500
2025-09-30 $1,566,560 4,000
2025-06-30 $45,855 103
2025-06-30 $133,560 300
2025-06-30 $133,560 300
2025-03-31 $242,410 500
2025-03-31 $132,355 273
2024-09-30 $139,524 300
2024-09-30 $139,524 300
2024-09-30 $80,923 174
2024-03-31 $412,157 986
2022-12-31 $2,916,678 10,100
2022-12-31 $2,916,678 10,100
2022-09-30 $11,610,554 40,100
2022-09-30 $14,534,908 50,200
2021-09-30 $1,631,603 8,995
2021-03-31 $2,041,455 9,500
2021-03-31 $1,191,994 5,547
2020-12-31 $750,143 3,174
2020-12-31 $2,245,230 9,500
2020-09-30 $544,240 2,000
2020-09-30 $405,458 1,490
2020-06-30 $2,583,759 8,900
2020-06-30 $111,188 383
2020-06-30 $2,903,100 10,000